hydrocodone

FDA takes tough stance on kids’ opioid cold medsFDA is taking its toughest stance yet on opioid-containing cough and cold medications for children.
FDA: Opioid Cold Meds Not Safe for Kids
FDA: Opioid Cold Meds Not Safe for KidsThe agency’s ruling also added an additional Boxed Warning.
DEA wants to slash opioid productionThe Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
Safeway Pharmacy Pays $3 Million After DOJ Investigation
Safeway Pharmacy Pays $3 Million After DOJ InvestigationThe chain is accused of not reporting opioid thefts by its employees.
Fighting Opioid Misuse: The Numbers
Fighting Opioid Misuse: The NumbersSo just how much naloxone is getting out? How many pharmacies EPCS enabled?
DEA slashes opioid drug productionThe US Drug Enforcement Administration (DEA) has reduced the amount of almost every Schedule II opiate and opioid medication that may be manufactured in the US by 25% or more.
Four developments helping address the opioid epidemicAs the opioid epidemic continues across the U.S., new treatment programs and guidelines could help reverse the trend.
FDA requires warning on opioidsA month after FDA announced several measures aimed at curbing opioid abuse, the agency said it would require a new boxed warning addressing the serious risk of misuse, abuse, addiction, overdose and death on immediate-release (IR) opioid pain medications.
Balancing opioid benefits, dangersOpioids are powerful clinical tools that effectively treat pain and have a place in therapy, but it can be difficult to manage the dangers. Here's a look at some of the abuse-deterrent drugs on the horizon.
FDA panel greenlights Probuphine for opioid addictionFDA advisers recommended approval of the first long-acting, subdermal buprenorphine implant (Probuphine, Titan Pharmaceuticals, Inc. and Braeburn Pharmaceuticals) for the maintenance treatment of opioid addiction.